vs

Side-by-side financial comparison of Krystal Biotech, Inc. (KRYS) and Resolute Holdings Management, Inc. (RHLD). Click either name above to swap in a different company.

Resolute Holdings Management, Inc. is the larger business by last-quarter revenue ($117.7M vs $107.1M, roughly 1.1× Krystal Biotech, Inc.). Krystal Biotech, Inc. runs the higher net margin — 48.0% vs -1.5%, a 49.4% gap on every dollar of revenue. Resolute Holdings Management, Inc. produced more free cash flow last quarter ($189.2M vs $75.4M).

Krystal Biotech, Inc. is a clinical-stage biotechnology company specializing in the research, development and commercialization of novel gene therapies for rare, serious dermatological diseases with high unmet medical needs. It primarily serves patients across North America and Europe, focusing on monogenic skin disorders that lack effective standard treatment options.

Resolute Mining Limited is an Australian mining corporation focused on mining operations in Africa. It is currently operating two gold mines: the Syama Gold Mine in Mali and the Mako Gold Mine in Senegal.

KRYS vs RHLD — Head-to-Head

Bigger by revenue
RHLD
RHLD
1.1× larger
RHLD
$117.7M
$107.1M
KRYS
Higher net margin
KRYS
KRYS
49.4% more per $
KRYS
48.0%
-1.5%
RHLD
More free cash flow
RHLD
RHLD
$113.9M more FCF
RHLD
$189.2M
$75.4M
KRYS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
KRYS
KRYS
RHLD
RHLD
Revenue
$107.1M
$117.7M
Net Profit
$51.4M
$-1.7M
Gross Margin
55.7%
Operating Margin
41.5%
30.2%
Net Margin
48.0%
-1.5%
Revenue YoY
17.5%
Net Profit YoY
13.0%
EPS (diluted)
$1.69
$-0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KRYS
KRYS
RHLD
RHLD
Q4 25
$107.1M
$117.7M
Q3 25
$97.8M
$120.9M
Q2 25
$96.0M
$119.6M
Q1 25
$88.2M
$103.9M
Q4 24
$91.1M
Q3 24
$83.8M
Q2 24
$70.3M
Q1 24
$45.3M
Net Profit
KRYS
KRYS
RHLD
RHLD
Q4 25
$51.4M
$-1.7M
Q3 25
$79.4M
$-231.0K
Q2 25
$38.3M
$-611.0K
Q1 25
$35.7M
$-3.4M
Q4 24
$45.5M
Q3 24
$27.2M
Q2 24
$15.6M
Q1 24
$932.0K
Gross Margin
KRYS
KRYS
RHLD
RHLD
Q4 25
55.7%
Q3 25
59.0%
Q2 25
57.5%
Q1 25
52.5%
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
KRYS
KRYS
RHLD
RHLD
Q4 25
41.5%
30.2%
Q3 25
42.3%
34.3%
Q2 25
40.9%
34.0%
Q1 25
41.0%
24.7%
Q4 24
45.4%
Q3 24
26.8%
Q2 24
12.2%
Q1 24
-14.8%
Net Margin
KRYS
KRYS
RHLD
RHLD
Q4 25
48.0%
-1.5%
Q3 25
81.2%
-0.2%
Q2 25
39.9%
-0.5%
Q1 25
40.5%
-3.2%
Q4 24
49.9%
Q3 24
32.4%
Q2 24
22.2%
Q1 24
2.1%
EPS (diluted)
KRYS
KRYS
RHLD
RHLD
Q4 25
$1.69
$-0.20
Q3 25
$2.66
$-0.03
Q2 25
$1.29
$-0.07
Q1 25
$1.20
$-0.39
Q4 24
$1.53
Q3 24
$0.91
Q2 24
$0.53
Q1 24
$0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KRYS
KRYS
RHLD
RHLD
Cash + ST InvestmentsLiquidity on hand
$496.3M
$205.5M
Total DebtLower is stronger
$169.8M
Stockholders' EquityBook value
$1.2B
$6.5M
Total Assets
$1.3B
$333.4M
Debt / EquityLower = less leverage
26.03×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KRYS
KRYS
RHLD
RHLD
Q4 25
$496.3M
$205.5M
Q3 25
$392.6M
$148.0M
Q2 25
$353.8M
$99.9M
Q1 25
$308.8M
$71.0M
Q4 24
$344.9M
Q3 24
$374.0M
Q2 24
$345.8M
Q1 24
$359.0M
Total Debt
KRYS
KRYS
RHLD
RHLD
Q4 25
$169.8M
Q3 25
$173.4M
Q2 25
$177.1M
Q1 25
$180.7M
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
KRYS
KRYS
RHLD
RHLD
Q4 25
$1.2B
$6.5M
Q3 25
$1.1B
$10.8M
Q2 25
$1.0B
$9.6M
Q1 25
$984.7M
$8.9M
Q4 24
$946.4M
Q3 24
$885.8M
Q2 24
$838.9M
Q1 24
$799.2M
Total Assets
KRYS
KRYS
RHLD
RHLD
Q4 25
$1.3B
$333.4M
Q3 25
$1.2B
$293.2M
Q2 25
$1.1B
$253.3M
Q1 25
$1.1B
$214.3M
Q4 24
$1.1B
Q3 24
$982.3M
Q2 24
$917.7M
Q1 24
$853.3M
Debt / Equity
KRYS
KRYS
RHLD
RHLD
Q4 25
26.03×
Q3 25
16.01×
Q2 25
18.42×
Q1 25
20.38×
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KRYS
KRYS
RHLD
RHLD
Operating Cash FlowLast quarter
$77.5M
$196.1M
Free Cash FlowOCF − Capex
$75.4M
$189.2M
FCF MarginFCF / Revenue
70.4%
160.8%
Capex IntensityCapex / Revenue
2.0%
5.8%
Cash ConversionOCF / Net Profit
1.51×
TTM Free Cash FlowTrailing 4 quarters
$188.9M
$313.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KRYS
KRYS
RHLD
RHLD
Q4 25
$77.5M
$196.1M
Q3 25
$39.7M
$59.6M
Q2 25
$52.7M
$48.9M
Q1 25
$31.0M
$18.4M
Q4 24
$52.8M
Q3 24
$58.9M
Q2 24
$-4.2M
Q1 24
$15.9M
Free Cash Flow
KRYS
KRYS
RHLD
RHLD
Q4 25
$75.4M
$189.2M
Q3 25
$38.0M
$58.6M
Q2 25
$50.8M
$47.5M
Q1 25
$24.8M
$17.8M
Q4 24
$52.0M
Q3 24
$57.8M
Q2 24
$-5.3M
Q1 24
$14.6M
FCF Margin
KRYS
KRYS
RHLD
RHLD
Q4 25
70.4%
160.8%
Q3 25
38.8%
48.5%
Q2 25
52.9%
39.7%
Q1 25
28.1%
17.1%
Q4 24
57.1%
Q3 24
69.0%
Q2 24
-7.5%
Q1 24
32.3%
Capex Intensity
KRYS
KRYS
RHLD
RHLD
Q4 25
2.0%
5.8%
Q3 25
1.7%
0.8%
Q2 25
2.0%
1.2%
Q1 25
7.0%
0.6%
Q4 24
0.9%
Q3 24
1.2%
Q2 24
1.6%
Q1 24
2.8%
Cash Conversion
KRYS
KRYS
RHLD
RHLD
Q4 25
1.51×
Q3 25
0.50×
Q2 25
1.38×
Q1 25
0.87×
Q4 24
1.16×
Q3 24
2.17×
Q2 24
-0.27×
Q1 24
17.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons